Impulse control disorders in patients with dopamine agonist-treated pituitary adenomas: a cross-sectional multicenter study

ConclusionICDs with a broad range of psychiatric symptoms are common in individuals with DA-treated prolactinoma and NFPAs. Endocrinologists should be aware of this potential side effect, particularly in patients and those a personal history of psychiatric disorder.
Source: Pituitary - Category: Endocrinology Source Type: research